Antibiotic selection for schistosome transgenesis

血吸虫转基因的抗生素选择

基本信息

  • 批准号:
    8849840
  • 负责人:
  • 金额:
    $ 19.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-16 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We have developed a method to derive transgenic schistosomes that utilizes the murine leukemia virus (MLV) to transfect schistosome eggs. After infecting snails with miracidia from eggs transduced by the MLV retrovirus, genomic DNA from cercariae released from the snails revealed the presence of transgenes, demonstrating that retroviral transgenes had been transmitted through the asexual developmental cycle, and thereby confirming germline transgenesis. Transgenic cercariae could be cryopreserved and retained infectivity for mice, and were in turn transmitted through the sexual developmental (meiosis) cycle to produce F1 generations of transgenic schistosomes. High-throughput sequencing of genomic DNA from schistosome populations exposed to MLV mapped widespread and random insertion of transgenes throughout the genome, along each of the autosomes and sex chromosomes, validating the utility of this approach for insertional mutagenesis. These findings provided the first description of wide-scale, random insertional mutagenesis of chromosomes and of germline transmission of a transgene in schistosomes. Here we propose to enhance our successful approach to schistosome transgenesis by the addition of antibiotic selection of transgenic schistosomes. Drug selection is widely used in transgene studies of microbial pathogens, mammalian cell and plant cell lines. Drug selection of transgenic schistosomes would provide a means to enrich for populations of transgenic worms. Recently we have demonstrated that MLV-transduced schistosomules expressing a neomycin resistance marker could be rescued on the aminoglycoside antibiotic, geneticin (G418). We hypothesize, based on these preliminary findings, that transgenic lines of schistosomes can be established by transducing the zygote within the schistosome eggshell and subsequently infecting snails with the resulting miracidia using concurrent selection on antibiotics to rescue transgenic worms and eliminating wild type worms or transgenic worms not expressing the drug resistance maker. Our three specific aims are: Aim 1. Investigate sensitivity of Schistosoma mansoni eggs to three discrete classes of antibiotics: (1) aminoglycosides e.g. G418; (2) aminonucleosides e.g. puromycin; 3) glycopeptides e.g. zeocin - for which selectable markers for all three categories are readily available. Aim 2. Optimization of antibiotic resistance gene expression in retrovirus-transduced and transgenic schistosomes. Aim 3. Antibiotic selection of retrovirus-transduced schistosome developmental stages, in particular in vitro laid eggs, on these antibiotics. The availability of antibiotic selection can be expected to enhance functional genomics and research progress on helminth parasites responsible for major neglected tropical diseases.
描述(由申请人提供):我们已经开发了一种利用鼠白血病病毒(MLV)来转染染色体卵的方法来获得转基因染色体。用来自MLV逆转录病毒转导卵的毛蚴感染蜗牛后,从蜗牛释放的尾蚴的基因组DNA揭示了转基因的存在,表明逆转录病毒转基因已通过无性发育周期传播,从而证实了种系转基因。转基因尾蚴经冷冻保存后,可保持对小鼠的感染性,并通过性发育(减数分裂)周期传递,产生F1代转基因尾蚴。来自暴露于MLV的多染色体群体的基因组DNA的高通量测序映射了转基因在整个基因组中的广泛和随机插入,沿着每个常染色体和性染色体,验证了该方法用于插入诱变的实用性。这些发现首次描述了染色体的大规模随机插入诱变和转基因在染色体中的种系传递。在这里,我们建议通过添加转基因染色体的抗生素选择来增强我们成功的染色体转基因方法。药物选择广泛用于微生物病原体、哺乳动物细胞和植物细胞系的转基因研究。转基因虫体的药物筛选将为转基因蠕虫的种群富集提供一种手段。最近,我们已经证明,MLV转导的表达新霉素耐药标记物的染色体可以在氨基糖苷类抗生素遗传霉素(G418)上被拯救。我们假设,基于这些初步的研究结果,可以建立转基因系的螺旋体转导受精卵内的螺旋体蛋壳,随后感染螺与由此产生的毛蚴使用抗生素的同时选择拯救转基因蠕虫和消除野生型蠕虫或转基因蠕虫不表达耐药性标记。我们的三个具体目标是:目标1。研究曼氏血吸虫卵对三种不同类别抗生素的敏感性:(1)氨基糖苷类,如G418;(2)氨基糖苷类,如嘌呤霉素;(3)糖肽类,如博莱霉素-所有三种类别的选择性标记都很容易获得。目标2.抗生素抗性基因在逆转录病毒转导和转基因染色体中表达的优化。目标3.逆转录病毒转导的染色体发育阶段的抗生素选择,特别是在体外产卵,对这些抗生素。抗生素选择的可用性有望提高功能基因组学和对主要被忽视的热带疾病的蠕虫寄生虫的研究进展。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul J Brindley其他文献

Programmed knockout mutation of liver fluke granulin , Ov-grn-1 , attenuates 1 virulence and impedes malignant transformation during chronic 2 opisthorchiasis 3 4 5
肝吸虫颗粒蛋白 , Ov-grn-1 的程序性敲除突变,减弱 1 毒力并阻止慢性 2 阿片吸虫病期间的恶性转化 3 4 5
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sujittra Chaiyadet;S. Tangkawattana;M. Smout;Wannaporn;Ittiprasert;V. Mann;Raksawan Deenonpoe;P. Arunsan;Alex;Loukas;Paul J Brindley;T. Laha
  • 通讯作者:
    T. Laha

Paul J Brindley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul J Brindley', 18)}}的其他基金

Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8371253
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    9107394
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10453668
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8549169
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8707832
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Targeting parasite-host communication to combat liver fluke-induced bile duct cancer
针对寄生虫与宿主的通讯来对抗肝吸虫诱发的胆管癌
  • 批准号:
    10226900
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Role of liver fluke granulin in cholangiocarcinogenesis
肝吸虫颗粒蛋白在胆管癌发生中的作用
  • 批准号:
    8716242
  • 财政年份:
    2012
  • 资助金额:
    $ 19.81万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7799460
  • 财政年份:
    2009
  • 资助金额:
    $ 19.81万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7846579
  • 财政年份:
    2009
  • 资助金额:
    $ 19.81万
  • 项目类别:
Transduction of Schistosoma mansoni by pseudotyped retrovirus
假型逆转录病毒转导曼氏血吸虫
  • 批准号:
    7211226
  • 财政年份:
    2007
  • 资助金额:
    $ 19.81万
  • 项目类别:

相似海外基金

Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    10585038
  • 财政年份:
    2023
  • 资助金额:
    $ 19.81万
  • 项目类别:
Creation of Next-generation Aminoglycoside Antibiotics Active against Multidrug-resistant Gram-negative Bacteria
开发对多重耐药革兰氏阴性菌具有活性的下一代氨基糖苷类抗生素
  • 批准号:
    20K06982
  • 财政年份:
    2020
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9934590
  • 财政年份:
    2019
  • 资助金额:
    $ 19.81万
  • 项目类别:
Combating Antibiotic Resistance to Aminoglycoside Antibiotics through Chemical Synthesis
通过化学合成对抗氨基糖苷类抗生素的耐药性
  • 批准号:
    392481159
  • 财政年份:
    2017
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Research Fellowships
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
打造下一代氨基糖苷类抗生素治疗多重耐药性疾病
  • 批准号:
    9082038
  • 财政年份:
    2016
  • 资助金额:
    $ 19.81万
  • 项目类别:
Functional analysis of radical SAM enzymes involved in the biosynthesis of aminoglycoside antibiotics
氨基糖苷类抗生素生物合成中自由基SAM酶的功能分析
  • 批准号:
    26410174
  • 财政年份:
    2014
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EAPSI:Synthesis of Aminoglycoside Antibiotics
EAPSI:氨基糖苷类抗生素的合成
  • 批准号:
    1106886
  • 财政年份:
    2011
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Fellowship Award
Preclinical evaluation of aminoglycoside antibiotics-derived amphiphiles (AADAs)
氨基糖苷类抗生素衍生的两亲物 (AADA) 的临床前评估
  • 批准号:
    185482
  • 财政年份:
    2009
  • 资助金额:
    $ 19.81万
  • 项目类别:
    Operating Grants
AMINOGLYCOSIDE ANTIBIOTICS FOR CYSTIC FIBROSIS
治疗囊性纤维化的氨基糖苷类抗生素
  • 批准号:
    6565399
  • 财政年份:
    2001
  • 资助金额:
    $ 19.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了